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Abstract
Objective This study was performed to determine whether
students who are trained in developing a personal formulary
become more competent in rational prescribing than
students who have only learned to use existing formularies.
Methods This was a multicentre, randomised, controlled
study conducted in eight universities in India, Indonesia,
the Netherlands, the Russian Federation, Slovakia, South
Africa, Spain and Yemen. Five hundred and eighty-three
medical students were randomised into three groups: the
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Geneva, Switzerlandpersonal formulary group (PF; 94), the existing formulary
group (EF; 98) and the control group (C; 191). The PF
group was taught how to develop and use a personal
formulary, whereas e the EF group was taught how to
review and use an existing formulary. The C group received
no additional training and participated only in the tests.
Student’s prescribing skills were measured by scoring their
treatment plans for written patient cases.
Results The mean PF group score increased by 23%
compared with 19% for the EF group (p<0.05) and 6%
for controls (p<0.05). The positive effect of PF training
was only significant in universities that had a mainly classic
curriculum.
Conclusion Training in development and use of a personal
formulary was particularly effective in universities with a
classic curriculum and with traditional pharmacology
teaching. In universities with a general problem-based
curriculum, pharmacotherapy teaching can be based on
either existing or personal formularies.
Keywords Personalformulary.Rationalprescribing.
Prescribing.Drugtreatment.Undergraduatemedical
education
Introduction
Many medical schools in developed as well as developing
countries are changing their undergraduate education in
pharmacotherapy from classic lecture-based learning to
problem-based learning (PBL). They are moving away
from the presentation of classic pharmacological knowl-
edge on medicines towards promoting problem-solving and
prescribing skills [1, 2]. The World Health Organisation
(WHO) Guide to Good Prescribing and several training
courses on problem-based pharmacotherapy teaching have
contributed to this development [3, 4].
The WHO Guide to Good Prescribing gives medical
students a normative model for therapeutic reasoning and
prescribing and provides a six-step guide to the process of
rational prescribing: (1) define the patient’s problem, (2)
specify the therapeutic objective, (3) choose a (drug)
treatment, (4) write the prescription and start the treatment,
(5) give patient information and warnings, and (6) monitor
the treatment. One of the key principles of the WHO
approach is the division of step 3 [choose a (drug)
treatment] into two steps. Step 3a, consider the suitability
of a standard (p-drug) treatment for the disease in general,
and step 3b, verify its suitability for the particular patient
and alter the (drug) treatment if necessary. Consequently,
undergraduate students are taught how to define their own
p-drugs and are encouraged during their medical education
and clinical activities to develop a personal formulary [5].
The WHO method emphasises that future doctors
should master both steps of the drug-selection process.
Selecting a p-drug trains students in pharmacological,
clinical and epidemiological principles and in collecting
and comparing evidence. By considering various treat-
ment alternatives when developing their personal formu-
lary, students are able to choose an alternative drug
treatment more rationally when the drug of first choice is
not suitable for a particular patient; for example, because
of contraindications or side effects. In addition, by
considering treatment alternatives, students are able to
evaluate the information provided about new drugs
during their professional career more critically.
Application of the WHO method has improved the
prescribing skills of undergraduate medical students [4].
However, it is not known to what extent the p-drug concept
and developing a personal formulary has contributed to this
improvement. Some have argued that existing formularies
and standard treatment guidelines, developed by experts,
would lead to better prescribing than would a personal
formulary developed by students. Furthermore, doctors are
usually expected to work within the limitations of existing
hospital formularies or practice guidelines. Despite the fact
that teaching the p-drug concept and developing a personal
formulary is a challenging and time-consuming task, we
hypothesise that training in developing a personal formu-
lary would lead to increased prescribing skills compared
with using an existing formulary.
Therefore, the aim of this study was to determine
whether there is a difference in prescribing skills between
medical students who have been trained in creating and
using a personal formulary and those who have been
trained in using existing formularies only.
Materials and methods
Study design
A randomised controlled pre and posttest design with three
arms was implemented (Fig. 1). All students participated in
a pretest. After the pretest at each university, students were
randomly divided into three equally sized groups: a
personal formulary (PF) group, an existing formulary (EF)
group and a control group. Students in the PF and EF
groups received two different training programmes before
taking the posttest. The control group received no addi-
tional training and was given only the pre- and posttests.
After the posttest, a structured questionnaire with 21
questions was administered to identify differences in the
type of teaching students received prior to the study. The
642 Eur J Clin Pharmacol (2008) 64:641–646questions were about two major teaching issues: curriculum
type; and teaching methods in pharmacology, clinical
pharmacology and pharmacotherapy. Other questions were
designed to verify whether the universities had carried out
the study in full accordance with the standard protocol. The
study was approved by the educational research committee
of the VU University Medical Center (VUMC).
Study population
Six hundred and nine undergraduate medical students
from eight countries were selected on a voluntary basis
(Vellore in India, Yogyakarta in Indonesia, Maastricht in
the Netherlands, Kazan in the Russian Federation,
Bratislava in Slovakia, CapeT o w ni nS o u t hA f r i c a ,L a
Laguna in Spain and Aden/Sana’a (jointly) in Yemen). All
students had passed their pharmacology examinations
(basicpharmacologyandclinicalpharmacology)andwere
about to start their clinical internships. Participation in the
study was in addition to their normal curriculum. All
students were informed in advance about the general aim
of the study and the method of testing. Cross-contamina-
tion of the students in the study groups and the control
g r o u pw a sp r e v e n t e db yg i v i n g the students in the control
group the opportunity to participate in a training
programme after the study.
Materials
For the intervention and tests, 16 written patient cases were
developed using four clinical subjects (A–D), each with a
different level of complexity (1–4) (Fig. 1). All cases were
formulated according to a standard design:
– General patient information (e.g. age, gender, allergy,
occupation and pregnancy)
– Summary of previous and current diseases and treat-
ments (comorbidity and comedication)
– Extensive description of the present history and a
physical examination
– Diagnosis
Each case differed in disease severity and complicating
factors such as age, comorbidity and comedication, drug
allergy, pregnancy and breast feeding. All three study
groups received a copy of the British National Formulary
(BNF) as a drug reference [6]. In addition, the PF group
received the WHO Guide to Good Prescribing, whereas the
EF group received an adapted version of the guide without
the chapters about the p-drug concept. The EF group also
received the Oxford Formulary, containing treatment advice
for symptoms and diseases that occur frequently in general
practice, including the four clinical subjects used in this
study [7].
Intervention
The training course for the PF and EF groups lasted for
5 weeks. The intervention for both groups consisted of an
introductory session and four training sessions (Fig. 1)—
one per week for about 2 h. The chosen teaching time was
based on earlier experiences with teaching programmes
using the PF concept [4, 8]. In the introductory session, the
WHO step-wise approach to prescribing drugs, was
explained. However, the p-drug concept was explained
only to the PF group. In each training session, two written
patient cases of one clinical subject were discussed.
Students completed a treatment plan form, following the
six steps of the WHO model. The students prepared for the
sessions by studying the treatment of the clinical subject but
in different ways. The PF group was asked to make an
inventory of available treatments and select a p-drug from
this group (on the basis of efficacy, safety, suitability and
cost), whereas the EF group was asked to study the relevant
treatment guidelines of the Oxford Formulary. One facili-
tator per university supervised the sessions of both PF and
EF groups only by guiding the discussions and clarifying
aspects of the case if necessary. Facilitators were specifi-
cally instructed not to provide solutions to the patient
problems but only to advise students on how to solve these
themselves. All facilitators had received specific training on
this teaching methodology in a research meeting at the
VUMC. The control group received no additional training
Training sessions / Intervention 
Pre-test   Group  1  2  3  4  5   Post-test  
A1, B2, C3, D4    PF  Introduct. PF  A3, A4  B1, B4  C1, C2  D2, D3    A2, B3, C4, D1 
  A1, B2, C3, D4    EF  Introduct. EF  A3, A4  B1, B4  C1, C2  D2, D3    A2, B3, C4, D1 
A1, B2, C3, D4    C    A2, B3, C4, D1 
Time:    Week 1  Week 2  Week 3  Week 4  Week 5  Week 6  Week 7 
Fig. 1 Study design: PF personal formulary group, EF existing
formulary group and C control group. Clinical subjects: A essential
hypertension, B osteoarthritis, C acute bronchitis and D gastroen-
teritis. Complexity levels: 1 straightforward case of a middle-aged
adult patient, 2 patient with a contraindication to a generally accepted
drug of first choice, 3 severe case and 4 case without effect of
previous treatment and side effects
Eur J Clin Pharmacol (2008) 64:641–646 643between the pre- and posttest but proceeded only with their
routine curriculum.
Test and scoring
The pre- and posttests consisted of four written patient
cases. Each case contained a different clinical problem of a
different level of complexity (Fig. 1). The combination
between the clinical problem and level of complexity were
randomly chosen. For each case, the students had to
complete a treatment plan form. They were allowed to use
any reference materials but not to consult one another.
Directly after the posttest, the answer sheets for both pre-
and posttests were blindly scored by the facilitator in a
standardised manner using a 5-point scale (0 = no answer,
1 = poor answer, 2 = arguable answer, 3 = acceptable
answer and 4 = good answer). Prior consensus about the
scoring system had been reached between all facilitators
during the research meeting at the VUMC. The scores were
sent to the researchers at the VUMC for analysis. Individual
student scores were not used by the participating universi-
ties for formal student assessments.
Statistical analysis
The results were analysed in SPSS 13.0 for Windows. The
scores on the six steps of the WHO model were clustered
into four prescribing skills: treatment choice, prescription
writing, patient information and treatment monitoring. The
differences between groups were analysed by analysis of
variance (ANOVA) with the university as a factor, as well
as separately. For pair-wise differences between the three
groups, a multiple comparison procedure was applied.
Significance was accepted at a two-tailed p<0.05. Only
the results of students who finished both pre- and posttest
were included in the analysis.
Results
A total of 609 students participated. Five hundred and
eighty-three students (96%) completed the pre- and post-
tests:194/203 (95.6%) students from the PF groups, 198/
203 (97.5%) from the EF groups and 191/203 (94.1%) from
the C groups. The three groups did not differ in their
averages for previous examination results and pretest
scores. The increases in the mean scores of the PF group
(0.93, 23%) and the EF group (0.78, 19%) were both
significantly higher than in the C group (0.23, 6%)
(Table 1). In addition, the increase in the PF group was
significantly higher than in the EF group (Table 1). Within
this total, the differences were significant for three of the
four prescribing skills (treatment choice, patient informa-
tion and monitoring treatment but not prescription writing)
and for three of the four complexity levels (straightforward
case, cases with a contraindication to first-line drugs and
severe cases but not cases with no effect of previous
treatment and side effects present) (data not shown).
Results of medical students from the eight universities
are listed separately (Table 1). In Yemen, the Russian
Federation and Indonesia, pretest scores were lower than in
the other five universities. In addition, the increase in their
scores was significantly higher in the PF groups than in the
EF groups. The differences among the PF and EF groups
were also significant for all levels of complexity and all
four prescribing skills (Fig. 2). In the remaining five
schools, there was no significant difference between the
PF and EF groups.
Table 1 Pre- and posttest scores per university
Nujmber Pretest Posttest
PF EF C PF EF C
Yemen 73 0.41 0.35 0.33 2.98
ab 1.56
b 0.46
Russia 88 0.83 0.91 0.87 1.83
ab 1.67
b 1.03
Indonesia 75 1.12 1.20 1.34 2.45
ab 1.98
b 1.42
Netherlands 64 2.20 2.06 2.25 3.04
b 3.06
b 2.63
c
Slovakia 72 2.27 2.13 2.12 3.20 3.12 2.90
c
India 72 2.17 2.39 2.23 2.19 2.51
b 2.08
Spain 73 2.38 2.33 2.28 2.61 2.76
b 2.36
South Africa 66 2.54 2.48 2.38 3.02 2.97 2.81
c
All Increase 583 1.71 1.62 1.69 2.64
a,b 0.93 (23%) 2.40
b 0.78 (19%) 1.92
c 0.23 (6%)
PF personal formulary group, EF existing formulary group, C control group
aPF > EF (p<0.05),
bPF, EF > C (p<0.05),
cC > pretest (p<0.05)
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teaching that students received indicated that Yemen, the
Russian Federation and Indonesia had a predominantly
classic curriculum. On average, the participating students
from these universities had received 90 h (range 52–160 h)
of pharmacology teaching by lectures, 23 h (range 3–50 h)
of clinical pharmacology teaching also by lectures and no
explicit pharmacotherapy teaching. These students were not
familiar with PBL but were somewhat accustomed to
discussion in small groups. The remaining five universities
had a predominantly problem-based teaching curriculum.
The participants had received an average of 43 h (range 6–
100 h) of pharmacology teaching by lectures, including
small group teaching; 24 h (range 6–40 h) of clinical
pharmacology teaching, mainly by small group teaching;
and no explicit pharmacotherapy teaching. The students
from these universities were all familiar with PBL and were
all accustomed to discussion in small groups. Some of these
students already had some clinical experience (Slovakia and
Spain). Except for the presence (or absence) of PBL, no
other differences in teaching could be identified between
any of the eight universities. No specific differences
between universities in the way the study was performed
or indications for possible bias were identified.
Discussion
The results of this study show that developing a personal
formulary and using an existing formulary both increase the
competence of medical students in rational prescribing.
However, the overall differences between the PF group and
the EF group (23% vs. 19% increase in mean score, p<
0.05) should be interpreted with caution. It is tempting to
conclude that teaching students to develop a personal
formulary adds to their prescribing skills. However, this
effect was only visible in the universities in Yemen, the
RussianFederation,andIndonesia.Nosignificantdifferences
between PF and EF scores were found in the universities in
the Netherlands, Slovakia, Spain, India or South Africa. A
possiblereasoncouldbethehighpretestscoresinthelastfive
universities, which reduced the likelihood of a significant
increaseafterarelativelyshortinterventionperiodof5weeks.
A similar effect was seen in the first multicountry study
where universities with a problem-based curriculum
showed less benefit from a short intervention course than
those without a problem-based curriculum [4].
An important question is why these five universities had
such high initial scores? The questionnaire was specifically
designed for the purpose of this study, and the only
explanation that emerged was that students from these five
universities had received problem-based teaching and were
therefore familiar with the process of solving patient
problems. In the universities with lower pretest scores,
classic teaching was paramount and students had less
experience with solving patient problems.
This finding is in accordance with the fact that
successful clinical problem solvers possess comprehensive
knowledge, but the way they organise and understand their
knowledge is even more critical. Modern teaching is aimed
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Fig. 2 Pre- and posttest scores
for different prescribing skills of
students from countries with a
traditional curriculum (Yemen,
the Russian Federation and
Indonesia). PF personal formu-
lary group (–), EF existing
formulary group (.....), C control
group (- -). Posttest scores are
annotated, # = PF > EF
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“search-and-retrieve” strategy for responding to complex
diagnostic problems [9, 10]. Students who were already
trained in this way via problem-based curricula seemed
better able to transfer this ability to therapeutic problem
solving and did not show an additional increase in such
skills when they participated in our study. However,
students from universities with a classic curriculum quickly
assimilated the p-drug concept, and their results came very
close to those of the other five universities, even after a
short intervention of only 5 weeks.
The limitations of our study need to be addressed. The
voluntary participation of students may have created a
positive bias for the total group, but allocation to the
intervention groups was randomised and therefore the
comparison was unbiased. In addition, to ensure baseline
comparability among the groups, previous results on
university examinations were averaged for the three groups.
The scoring by the medical schools was blinded, with the
pre- and posttest forms of all three groups being mixed
during the scoring. Cross-contamination between the study
and control groups was prevented by explaining to the
students the importance of not exchanging any information
and by reassuring the control group that it would receive
the training after finishing the study.
Therefore, taking the above-mentioned limitations and
considerations into account, it can be concluded that
training in developing and using a personal formulary or
in the use of an existing formulary may increase the rational
prescribing of medical students. However, with regard to
universities with a general problem-based curriculum,
training in the development of a personal formulary is
probably not worth the additional effort. In these circum-
stances, pharmacotherapy teaching can be based on existing
formularies instead of a personal formulary.
In this international study, only the short-term effects on
rational prescribing of developing a personal formulary or
using an existing formulary have been studied. Despite the
fact that the long-term effects are unknown, it can be
hypothesised that after developing a personal formulary,
students may judge new drugs more effectively and be
more capable of deciding whether or not to include these
drugs into their (personal) formulary. Furthermore, the
results may diminish the concerns ventilated by some
clinical pharmacology teachers regarding the changes in the
style of undergraduate medical curricula from classic to
PBL teaching [11, 12].
In practice, this implies that the decision to organise a
teaching programme for medical students on how to
develop and use a personal formulary needs to be based
on an initial assessment of both the students and the
curriculum. The same may be true for postgraduate and
continuing education of doctors who have been trained in
the classic manner [13, 14]. A screening test, such as the
pretest in this study, could perhaps be used to identify
universities, students or prescribers that would benefit most
from this type of training.
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